Mild cognitive impairment

…, P Scheltens, MC Tierney, P Whitehouse, B Winblad - The lancet, 2006 - thelancet.com
Mild cognitive impairment is a syndrome defined as cognitive decline greater than expected
for an individual's age and education level but that does not interfere notably with activities …

Current concepts in mild cognitive impairment

…, K Ritchie, M Rossor, L Thal, B Winblad - Archives of …, 2001 - jamanetwork.com
The field of aging and dementia is focusing on the characterization of the earliest stages of
cognitive impairment. Recent research has identified a transitional state between the …

Influence of social network on occurrence of dementia: a community-based longitudinal study

…, HX Wang, K Ericsson, M Maytan, B Winblad - The lancet, 2000 - thelancet.com
Background Few data are available on the effect of social ties on dementia development.
This study explored whether single social network components and different degrees of the …

An active and socially integrated lifestyle in late life might protect against dementia

L Fratiglioni, S Paillard-Borg, B Winblad - The Lancet Neurology, 2004 - thelancet.com
The recent availability of longitudinal data on the possible association of different lifestyles
with dementia and Alzheimer's disease (AD) allow some preliminary conclusions on this topic…

Defeating Alzheimer's disease and other dementias: a priority for European science and society

B Winblad, P Amouyel, S Andrieu, C Ballard… - The Lancet …, 2016 - thelancet.com
Alzheimer's disease (AD) is the leading cause of dementia, and because the primary risk
factor for AD is old age, the prevalence of the disease is increasing dramatically with ageing …

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

B Winblad, K Engedal, H Soininen, F Verhey… - Neurology, 2001 - AAN Enterprises
Objective: To evaluate the long-term clinical efficacy and safety of donepezil versus placebo
over 1 year in patients with mild to moderate AD. Methods: Patients (n = 286; mean age, …

Alzheimer's disease: clinical trials and drug development

F Mangialasche, A Solomon, B Winblad… - The Lancet …, 2010 - thelancet.com
Alzheimer's disease is the most common cause of dementia in elderly people. Research
into Alzheimer's disease therapy has been at least partly successful in terms of developing …

The age-dependent relation of blood pressure to cognitive function and dementia

C Qiu, B Winblad, L Fratiglioni - The Lancet Neurology, 2005 - thelancet.com
The relation of blood pressure with cognitive function and dementia has, in recent years,
received much attention from epidemiological research. Some cross-sectional studies have …

Clinical trials and late‐stage drug development for A lzheimer's disease: an appraisal from 1984 to 2014

…, P Mecocci, L Pani, B Winblad… - Journal of internal …, 2014 - Wiley Online Library
The modern era of drug development for A lzheimer's disease began with the proposal of
the cholinergic hypothesis of memory impairment and the 1984 research criteria for A …

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

…, K Axelman, H Houlden, L Lilius, B Winblad… - Nature …, 1992 - nature.com
Mutations at codon 717 in exon 17 of the β–amyloid precursor protein (APP) gene have
previously been shown to segregate with early onset Alzheimer's disease in some families. We …